Abstract
Despite potentially curative surgery, the incidence of recurrence of gastric carcinoma is relatively high. In addition to tumor aggressiveness and growth characteristics, surgical strategy is a determining factor in the frequency of recurrence.1–3 Recurrence can take the form of distant metastases or peritoneal carcinomatosis, hence reflecting disseminated tumor disease. At present no cure is possible in this situation. The degree to which cytostatic treatment, given an early diagnosis of metastases, leads to improved prognosis and whether cure may be achieved through renewed surgical treatment, given localized tumor recurrence, are unresolved issues. This is presumed in the requirement for routine follow-up care of gastric cancer patients following partial or total gastrectomy.4,5
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Herfarth C, Schlag P, Hohenberger P: Therapeutische Möglichkeiten bei locoregionären Rezidiven der Carcinome des Gastrointestinaltraktes. Chirurgie 1985; 56: 492.
Meyer H-J, Pichlmayr R: Patterns of recurrence in relation to therapeutic strategy in gastric cancer. Scand J Gastroenterol 1987; 2 (suppl 133): 45.
Schlag P, Herfarth C: Beziehung zwischen Ausdehnung des operativen Primäreingriffs und Häufigkeit lokoregionärer Rezidive, in Rohde H, Troidl H (eds): Das Magenkarzinom: Methodik klinischer Studien und therapeutischer Ansätze. Stuttgart, Georg Thieme, 1984, p. 138.
Huchzermeyer H, Meyer H-J: Die Nachsorge des magenresezierten Patienten, in Langhans P, Meyer H-J, Pichlmayr R (eds): Aktuelle Therapie des Magenkarzinoms. Berlin-Heidelberg-New York, Springer, 1985, p. 181.
Schlag P: Nachsorge des operierten Magenkarzinompatienten. Probleme beim magenlosen Patienten. Klinikarzt 1978; 7: 397.
Papachristou DN, Fortner JG: Local recurrence of gastric adenocarcinomas after gastrectomy. J Surg Oncol 1981; 18: 47.
Koga S, Kishimoto H, Tanaka K, et al: Clinical and pathologic evaluation of patients with recurrence of gastric cancer more than five years postoperatively. Am J Surg 1978; 136: 317.
Metzger U, Kupfer A, Hollinger A, et al: Tumornachsorge beim radikaloperierten Magenkarzinom. Eine prospektive Studie, in Häring R (ed): Therapie des Magenkarzinoms, Ed Medizin. Basel, Weinheim, 1984, p. 433.
Quentmeier A, Schlag P, Schmidt-Gayk H, et al: Ca 19–9 und CEA: Fortschritt bei der Diagnose und Verlaufsbeobachtung des Magencarcinoms durch kombinierte Bestimmung zweier Tumormarker. Langenbecks Arch Chir 1984;(Congress report):540.
Schlag P, Buhl K, Beck J, et al: Indikationen und Möglichkeiten operativer Therapie beim Magenkarzinomrezidiv, in Langhans P, Meyer H-J, Pichlmayr R (eds): Aktuelle Therapie des Magenkarzinoms. Berlin-Heidelberg-New York, Springer, 1985, p. 129.
Allum WH, Hockey MS, Fielding JW: Gastric remnant recurrence—detection and implications for the management of gastric cancer. Clin Oncol 1984; 10: 333.
Schwemmle K, Helling HJ: Onkologische Nachsorge und chirurgische Therapie von Lokalrezidiv und Metastasen beim Magencarcinom, in Gall FP, Hermanek P, Hornig D (eds): Magenkarzinom: Epidermiologie, Pathologie, Therapie, Nachsorge. Munich, W Zuckschwerdt, 1986, p. 189.
Viste A, Rygh AB, Soreide O: Cancer of the stomach—is a follow-up program of any importance for the patient? Clin Oncol 1984; 10: 325.
Wenzl E, Feil W, Schiessel R: Wert einer konsequenten Nachsorge beim Magenkarzinom. Wien Klin Wschr 1987; 12: 420.
Suzuki H, Endo M, Nakayama K: A review of the five-year survival rate and clinicopathologic factors in stomach cancer treated by surgery alone. Intern Advances Surg Oncol 1983; 6: 271.
Schlag P, Merkle P, Herfarth C: Neue Aspekte in der Konzeption adjuvanter und nachsorgender Therapie des Magencarcinoms? Chirurg 1979; 50: 432.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag New York, Inc.
About this paper
Cite this paper
Schlag, P., Buhl, K., Herfarth, C. (1989). Follow-Up Care and Surgery for Recurrent Gastric Cancer. In: Hotz, J., Meyer, HJ., Schmoll, HJ. (eds) Gastric Carcinoma. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3636-8_9
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3636-8_9
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-96955-8
Online ISBN: 978-1-4612-3636-8
eBook Packages: Springer Book Archive